Last updated: May 16, 2024
Sponsor: Valentina Garibotto
Overall Status: Active - Recruiting
Phase
N/A
Condition
Cancer
Treatment
PET/CT with FDG or FES
Clinical Study ID
NCT06424873
2023-02102
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Patients clinically indicated for whole-body PET evaluation.
Patient must agree to lie still in the camera.
Patient must be able to comply with study procedures.
Patient must be able to provide informed consent.
Exclusion
Exclusion Criteria:
Patients < 18 years of age.
Pregnant women are excluded.
Study Design
Total Participants: 60
Treatment Group(s): 1
Primary Treatment: PET/CT with FDG or FES
Phase:
Study Start date:
April 01, 2024
Estimated Completion Date:
December 31, 2025
Study Description
Connect with a study center
Geneva University Hospitals
Geneva, 1205
SwitzerlandActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.